Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-Dose PegIFN-a-2a + Ribavirin for HCV in HIV Co-infection
NCT00553930Phase 4Completed
- Sponsor
- Sociedad Andaluza de Enfermedades Infecciosas
- Start
- Nov 2007
- Primary completion
- May 2010
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 4 trial of peginterferon alfa-2a in hepatitis C (HCV), sponsored by Sociedad Andaluza de Enfermedades Infecciosas. Started Nov 2007; status: completed.
02
Drugs
peginterferon alfa-2a
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00553930.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00553930.